|
PBK expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.070300E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.687700E-02 |
| Normal-vs-Stage2 |
5.389800E-01 |
| Normal-vs-Stage3 |
1.822220E-01 |
| Normal-vs-Stage4 |
5.251700E-02 |
| Stage1-vs-Stage2 |
3.166000E-01 |
| Stage1-vs-Stage3 |
7.555200E-01 |
| Stage1-vs-Stage4 |
4.276600E-01 |
| Stage2-vs-Stage3 |
5.305600E-01 |
| Stage2-vs-Stage4 |
1.733170E-01 |
| Stage3-vs-Stage4 |
3.924800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.079700E-02 |
| Normal-vs-AfricanAmerican |
3.718000E-01 |
| Normal-vs-Asian |
2.584600E-01 |
| Caucasian-vs-AfricanAmerican |
7.053200E-01 |
| Caucasian-vs-Asian |
6.615000E-01 |
| AfricanAmerican-vs-Asian |
9.673000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.988100E-02 |
| Normal-vs-Female |
8.026200E-02 |
| Male-vs-Female |
4.922000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.975980E-02 |
| Normal-vs-Age(41-60Yrs) |
6.589000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.368570E-01 |
| Normal-vs-Age(81-100Yrs) |
1.028760E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.516210E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.169200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.016000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.508000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.134150E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.679760E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.119400E-01 |
| Classical-VS-Follicular |
2.029600E-02 |
| Classical-VS-Other |
5.022600E-01 |
| Classical-VS-Normal |
2.816000E-02 |
| Tall-VS-Follicular |
1.191760E-01 |
| Tall-VS-Other |
3.987800E-01 |
| Tall-VS-Normal |
1.197750E-01 |
| Follicular-VS-Other |
9.172600E-01 |
| Follicular-VS-Normal |
7.346400E-01 |
| Other-VS-Normal |
7.062800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.575810E-01 |
| Normal-vs-N1 |
3.080400E-01 |
| N0-vs-N1 |
5.686200E-01 |
|
|
